Kidney Genetics Group, Academic Unit of Nephrology, The Henry Wellcome Laboratories for Medical Research, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, United Kingdom.
J Biol Chem. 2011 May 27;286(21):18994-9000. doi: 10.1074/jbc.M110.192286. Epub 2011 Apr 7.
Autosomal dominant polycystic kidney disease (ADPKD), the most common inherited cause of kidney failure, is caused by mutations in either PKD1 (85%) or PKD2 (15%). The PKD2 protein, polycystin-2 (PC2 or TRPP2), is a member of the transient receptor potential (TRP) superfamily and functions as a nonselective calcium channel. PC2 has been found to form oligomers in native tissues, suggesting that similar to other TRP channels, it may form functional homo- or heterotetramers with other TRP subunits. We have recently demonstrated that the homodimerization of PC2 is mediated by both N-terminal and C-terminal domains, and it is known that PC2 can heterodimerize with PC1, TRPC1, and TRPV4. In this paper, we report that a single cysteine residue, Cys(632), mutated in a known PKD2 pedigree, constitutes the third dimerization domain for PC2. PC2 truncation mutants lacking both N and C termini could still dimerize under nonreducing conditions. Mutation of Cys(632) alone abolished dimerization in these mutants, indicating that it was the critical residue mediating disulfide bond formation between PC2 monomers. Co-expression of C632A PC2 mutants with wild-type PC2 channels reduced ATP-sensitive endoplasmic reticulum Ca(2+) release in HEK293 cells. The combination of C632A and mutations disrupting the C-terminal coiled-coil domain (Val(846), Ile(853), Ile(860), Leu(867) or 4M) nearly abolished dimer formation and ATP-dependent Ca(2+) release. However, unlike the 4M PC2 mutant, a C632A mutant could still heterodimerize with polycystin-1 (PC1). Our results indicate that PC2 homodimerization is regulated by three distinct domains and that these events regulate formation of the tetrameric PC2 channel.
常染色体显性多囊肾病 (ADPKD) 是最常见的肾衰竭遗传性病因,由 PKD1(85%)或 PKD2(15%)基因突变引起。PKD2 蛋白,多囊蛋白-2(PC2 或 TRPP2),是瞬时受体电位 (TRP) 超家族的成员,作为非选择性钙通道发挥作用。已经发现 PC2 在天然组织中形成寡聚体,这表明与其他 TRP 通道类似,它可能与其他 TRP 亚基形成功能性同源或异源四聚体。我们最近证明了 PC2 的同源二聚化由 N 端和 C 端结构域介导,并且已知 PC2 可以与 PC1、TRPC1 和 TRPV4 异二聚化。在本文中,我们报告了一个位于已知 PKD2 家系中的单个半胱氨酸残基 Cys(632),是 PC2 的第三个二聚化结构域。缺乏 N 和 C 末端的 PC2 截断突变体在非还原条件下仍能二聚化。仅突变 Cys(632)就会使这些突变体中的二聚化作用丧失,表明它是介导 PC2 单体之间二硫键形成的关键残基。与野生型 PC2 通道共表达 C632A PC2 突变体可减少 HEK293 细胞中 ATP 敏感的内质网 Ca2+释放。C632A 与破坏 C 端卷曲螺旋结构域的突变体(Val(846)、Ile(853)、Ile(860)、Leu(867)或 4M)的组合几乎完全抑制二聚体形成和 ATP 依赖性 Ca2+释放。然而,与 4M PC2 突变体不同,C632A 突变体仍能与多囊蛋白-1(PC1)异二聚化。我们的结果表明,PC2 同源二聚化受三个不同的结构域调节,这些事件调节四聚体 PC2 通道的形成。